JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for RADSTATS Archives


RADSTATS Archives

RADSTATS Archives


RADSTATS@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

RADSTATS Home

RADSTATS Home

RADSTATS  March 2020

RADSTATS March 2020

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: Research on flattening of the curve of COVID-19

From:

Andrei Morgan <[log in to unmask]>

Reply-To:

Andrei Morgan <[log in to unmask]>

Date:

Wed, 18 Mar 2020 08:34:11 +0000

Content-Type:

multipart/signed

Parts/Attachments:

Parts/Attachments

text/plain (155 lines) , signature.asc (155 lines)

Hi John, hi all,

You raise a number of really interesting points, so I'm also replying to
the list (as you indicated you were ok with in a previous mail).... I am
not sure why you didn't send this mail there as it is a really good
example of a great and interesting mail that I am sure people would love
to read!

So, first point to address which I will also re-address is you are right,
list traffic seems to be a pendulum and has now hit near zero, can we
have a happy medium? I did not want to stop all discussion!

The issue regards testing is, clearly, a major issue in the UK - and
perhaps even more so in the USA. Simply put, if we don't test, we don't
know. But to me, the more important thing is to be very strict and clear
with diagnostic criteria: we saw that already with the Chinese in
January when they changed their diagnostic criteria overnight from those
with a positive PCR test to those with the clinical symptoms - the
numbers jumped and it appeared as if the epidemic had surged. In the UK,
to my mind the biggest problem is the government has not been
clear. Obviously testing is better than clinical diagnosis but mixing
the two (e.g. saying "you probaby have COVID-19 if you have these
symptoms, so stay home for 2 weeks" but only recording people with
positive PCR results in the figures) is actually pretty dangerous as you
just sow confusion.  That said, the most useful test is going to be when
we can measure antibodies - i.e. resistance to the disease. As far as I
know, that's not yet possible.

Regarding your question/point in relation to ITU provision... I trained
at Bristol in the South West in the 1990s. I remember the Care of the
Elderly ("geriatrics") placement that we did: like all the other
placements, people got posted from Truro to Gloucester. And the
definition of "elderly" varied very strongly by location, depending upon
the local demographic. In many/most places it was 70-75 - but in Torquay
the care of the elderly team only became involved with patients over 90!
Furthermore, the availability of resources will also influence things -
how many beds are there per local population (and what is that
population make-up)?  My second story related to this is that the
implementation of advanced medical technology is very related to (the
perception of) underlying pathology. If you have something that will get
better (pneumonia) you are much more likely to have aggressive treatment
initiated than if there is an irreversible condition (end stage lung
cancer, for example).

Best wishes,

     -- Andrei

On Wed, Mar 18, 2020 at 01:08:12AM +0000, John Whittington wrote:
>    Hi Andrei,
> 
>    At 23:44 17/03/2020, Andrei Morgan wrote:
> 
>      I've spent quite a lot of time today writing some analysis about it:
>      [1]https://www.andreimorgan.net/posts/covid_strategy/
> 
>    Many thanks - that's very interesting, so many thanks for all your
>    effort.  Needless to say, there are plenty of points you raise that I
>    would like to discuss, if there were time, but everything you write seems
>    very reasonable.
> 
>    If you have the time to read, just a couple of thoughts/questions ...
> 
>    Firstly, I'm not at all clear as to what the reported UK 'case' figures
>    will mean as we move forward.  Although the politicians are now promising
>    that we will 'do a lot more tests', I'm not at all clear on who we will be
>    testing, given that the advice given to the UK population a few days ago
>    seems to have cut off the supply of indicators of who should be tested. 
>    Maybe I'm missing something, but it looks as if the figures will come
>    increasingly to be dominated by those ill enough to require
>    hospitalisation, together with (mainly uninfected) healthcare workers.  In
>    particular, the potential contacts of those who have been infected cannot,
>    in general, now be detected and tested, because infected people have now
>    been instructed not to tell anyone who they are (unless they become
>    seriously ill)!
> 
>    Secondly, I'm just had a very interesting look around your website.  I
>    hadn't realised that you were a clinician, so I will try bounce a clinical
>    question off you.  We know that the majority of people who develop severe
>    illness (including those who die) will be elderly.  We are also seeing an
>    awful lot of excitement about the availability (or 'overwhelming') of ICU
>    resources and the need to manufacture a lot more ventilators etc.  This
>    leads me to wonder whether perhaps 'times (and expectations) have changed'
>    a lot more than I would have imagined.
> 
>    It's not a particularly comfortable thing for me to think about, given
>    that I am now a few months past my 70th birthday, but I think that if, ~30
>    years ago, I had suggested that a person in their 70s, let alone 80s, with
>    a life-threatening chest infection should be admitted to ICU/ITU and
>    ventilated, I might well have been laughed at - both because (even without
>    epidemics/pandemics) pressure on ICU beds was always very high but, also,
>    since it was generally believed that such a patient would be very unlikely
>    to survive even if they were ventilated - but maybe that wasn't correct,
>    since what you write in your.report implies that 50% of ventilated
>    patients with Covid-19 infection might actually survive.
> 
>    So I can't help but wonder whether things/expectations have changed.  I
>    suppose that I might gain some comfort from that, in as much as it seems
>    to imply that if I found myself suffering from a life-threatening viral
>    pneumonia I could expect to be ventilated (whereas just a few weeks ago I
>    would have doubted that anyone would consider doing that!) and that, if I
>    were ventilated, I might stand a 50% chance of surviving.  Is that how you
>    understand the present situation/intent/practice in the NHS?   I suppose
>    another possibility is that, ironically, expectations of treatment
>    available during a crisis situation such as we are in might be greater
>    than they would have been in a non-crisis situation - i.e. maybe I would
>    be ventilated because we are having a Covid-19 outbreak whereas I wouldn't
>    have been ventilated if I had been suffering from an equally severe chest
>    infection a few weeks earlier, but from a different cause?!
> 
>    As a final comment, it certainly does seem that (unless you believe in
>    co-incidences!) my taking my activities 'off-list' seems to have put a
>    stop to discussions about Covid-19 on RadStats - all we've really seen in
>    the past 24 hours are really a small handful of posts with links, and
>    nothing that I would call 'discussion'.  Although things were getting a
>    bit out of hand, I think it's a bit of a pity that we've seemingly 'gone
>    from the sublime to the ridiculous' - but maybe that's what people want!
> 
>    Thanks again, and try to keep safe.
> 
>    Kindest Regards,
> 
>    John
>    ----------------------------------------------------------------
>    Dr John Whittington,       Voice:    +44 (0) 1296 730225
>    Mediscience Services       Fax:      +44 (0) 1296 738893
>    Twyford Manor, Twyford,    E-mail:   [log in to unmask]
>    Buckingham  MK18 4EL, UK            
>    ----------------------------------------------------------------
> 
> References
> 
>    Visible links
>    1. https://www.andreimorgan.net/posts/covid_strategy/

-- 
Andrei Morgan MRCPCH, MSc, PhD (Epidemiology / Neonatology)
https://www.andreimorgan.net

Honorary Clinical Lecturer,
Department of Neonatology,
Institute for Women's Health,
University College London


******************************************************
Please note that if you press the 'Reply' button your
message will go only to the sender of this message.
If you want to reply to the whole list, use your mailer's
'Reply-to-All' button to send your message automatically
to [log in to unmask]
Disclaimer: The messages sent to this list are the views of the sender and cannot be assumed to be representative of the range of views held by subscribers to the Radical Statistics Group. To find out more about Radical Statistics and its aims and activities and read current and past issues of our newsletter you are invited to visit our web site www.radstats.org.uk.
*******************************************************

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager